Selection of frontline therapy for CLL. *BR is preferred over FCR for patients with moderate renal dysfunction and patients 65 years or older who are deemed appropriate for FCR therapy. Cbl, chlorambucil; FISH, fluorescence in situ hybridization; IWCLL, International Workshop on Chronic Lymphocytic Leukemia.